Clinical Trials Directory

Trials / Unknown

UnknownNCT04768595

Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)

A Nutritional, Placebo Controlled, Randomised, Blinded Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
56 (estimated)
Sponsor
Epax Norway AS · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The study determines the EPA DHA uptake from different omega-3 supplements against a control.

Detailed description

The chronic uptake of omega-3 fatty acids EPA and DHA are commonly determined by measurement of EPA and DHA in red bloods cells and presented as a % of total fatty acids, the so-called Omega-3 Index. The index is a validated risk assessment for cardiovascular disease. Different fish oils may influence the Omega-3 Index differently depending on their composition. This study assesses omega-3 commonly found as a supplement vs a fish oil based on north atlantic fish species.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlaceboTwo, 1g capsules taken daily with food
DIETARY_SUPPLEMENTCeto 10Two, 1g capsules daily with food
DIETARY_SUPPLEMENTFish oilTwo, 1g capsules daily with food

Timeline

Start date
2021-03-03
Primary completion
2021-06-30
Completion
2021-08-01
First posted
2021-02-24
Last updated
2021-02-24

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04768595. Inclusion in this directory is not an endorsement.